Skip to content

SABS

SAB Biotherapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.51
+0.29%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
1277.45x

Trailing multiples

Trailing twelve months

P/E TTM
0.98x
PEG TTM
Price / book
1.49x
Price / sales
Price / cash flow
-4.68x

Enterprise value

Enterprise value
$221.9M
EV / sales
EV / EBITDA
-23.45x
EV / EBIT
-3.09x
Market cap
$319.4M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026